Patrick Murphy is a Cardiology physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1700 Spring Hill Ave
Suite 100
Mobile, AL 366041407
Telephone
251-435-1200Registry record last updated 15 May 2008.
Clinical trials
- Continuation Of a Study to Investigate the Effect of Thoracocentesis on Neural Respiratory Drive in Pleural Effusion
Sponsor: Guy's and St Thomas' NHS Foundation Trust
- Efficacy of an Advanced Auto-titrating NIV in COPD
Sponsor: Guy's and St Thomas' NHS Foundation Trust
- Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20253 payments
- Lundbeck LLCProgram year20257 payments
- E.R. Squibb & Sons, L.L.C.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78%Beta blocker21.4%Carvedilol50%Metoprolol Succinate27%Metoprolol Tartrate21%Sotalol2%Part D<11 patientsStatin14.8%Atorvastatin Calcium51%Simvastatin21%Rosuvastatin Calcium17%Pravastatin Sodium10%Part D≥83 patients+ 15 more classes in this area
Blood & clotting
17.9%Factor Xa inhibitor10.4%Eliquis68%Xarelto32%Part D≥61 patientsP2Y12 inhibitor5.9%Clopidogrel93%Prasugrel Hcl7%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.9%Potassium supplement2.2%Potassium Chloride100%Part D≥25 patientsProton pump inhibitor0.7%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”